|09:30 – 09:50||Registration, refreshments and expenses|
|09:50 – 10:00||Welcome, introductions, UKCAB updates|
|10:00 – 11:15||TB and HIV: Screening and treatment– Dr Santino Capocci, Royal Free Hospital|
|11:15 – 11.30||Break|
|11:30 – 12.15||TB-HIV: Strengthening Community Response. – Gitau Mburu, Int. HIV/AIDS Alliance|
|12:15 – 12.45||Company pre-meeting on TMC207 – Polly Clayden, HIV i-Base|
|12:45 – 14:00||Lunch|
|14:15 – 15:30||Company meeting: Janssen|
|15.30 – 15.35||Break|
|15:35 – 16:00||UKCAB London drug survey feedback – Mark Platt|
What is TB? – Extracted from the i-Base treatment training for advocates
BHIVA guidelines for the treatment of TB/HIV coinfection 2011:
How TB is treated
Medicines for people with TB – contains 1st line, multi-drug resistant TB and extremely drug resistant TB medicines. There is also a section on pipeline drugs.
Global TB drug pipeline:
Faster conversion rates with TMC-207 versus placebo plus OBT for the treatment of MDR-TB – study on a new drug with the potential to improve both drug-sensitive and multi-drug resistant TB.
2011 pipeline report: 2nd edition (September 2011) – covers the most recent and exciting developments in HIV, hepatitis and TB research. [PDF download, 1MB]
TB in our Lives – A detailed guide by Treatment Action Campaign in South Africa, with emphasis on coinfection with HIV. Activists wrote the guide about how TB attacks the body, how it is treated and the things they can do to help fight TB in their communities.
They explain things in a way that makes sense and that is not too technical so that readers can go on and explain about TB to others. The guide has information sheets for people living with TB, support groups and clinics. [PDF download]